Summary of Bill SRES 257
Bill 118 sres 257, also known as the "Glioblastoma Awareness Day" resolution, aims to designate July 19, 2023, as a day to raise awareness about glioblastoma, a rare and aggressive form of brain cancer. The resolution highlights the need for increased research, funding, and support for individuals and families affected by this devastating disease.
Glioblastoma is known for its high mortality rate and limited treatment options, making it a significant public health concern. By designating a specific day to bring attention to glioblastoma, lawmakers hope to educate the public about the challenges faced by those living with the disease and the importance of early detection and treatment.
The resolution emphasizes the importance of supporting ongoing research efforts to improve outcomes for glioblastoma patients and ultimately find a cure for this deadly form of cancer. By raising awareness and advocating for increased resources, policymakers aim to make a meaningful impact on the lives of individuals and families affected by glioblastoma.
Overall, Bill 118 sres 257 seeks to shine a spotlight on glioblastoma and encourage greater awareness, support, and action to address this critical health issue. By officially recognizing July 19, 2023, as "Glioblastoma Awareness Day," lawmakers hope to inspire positive change and progress in the fight against this devastating disease.
Congressional Summary of SRES 257
This resolution designates Glioblastoma Awareness Day. Glioblastoma is a malignant brain tumor.